160 related articles for article (PubMed ID: 37750041)
1. Longitudinal dysregulation of long non-coding RNAs in Parkinson's disease.
Müller-Nedebock AC; Cuttler K; Pfaff AL; Kõks S
Exp Biol Med (Maywood); 2023 Oct; 248(20):1780-1784. PubMed ID: 37750041
[TBL] [Abstract][Full Text] [Related]
2. Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report.
Kraus TFJ; Haider M; Spanner J; Steinmaurer M; Dietinger V; Kretzschmar HA
Mol Neurobiol; 2017 May; 54(4):2869-2877. PubMed ID: 27021022
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease.
Rezaei O; Nateghinia S; Estiar MA; Taheri M; Ghafouri-Fard S
Eur J Pharmacol; 2021 Apr; 896():173914. PubMed ID: 33508286
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing.
Soreq L; Guffanti A; Salomonis N; Simchovitz A; Israel Z; Bergman H; Soreq H
PLoS Comput Biol; 2014 Mar; 10(3):e1003517. PubMed ID: 24651478
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement.
Garofalo M; Pandini C; Bordoni M; Pansarasa O; Rey F; Costa A; Minafra B; Diamanti L; Zucca S; Carelli S; Cereda C; Gagliardi S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327559
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
[TBL] [Abstract][Full Text] [Related]
7. A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra.
Simchovitz A; Hanan M; Yayon N; Lee S; Bennett ER; Greenberg DS; Kadener S; Soreq H
Aging Cell; 2020 Mar; 19(3):e13115. PubMed ID: 32080970
[TBL] [Abstract][Full Text] [Related]
8. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson's Disease.
Salemi M; Lanza G; Mogavero MP; Cosentino FII; Borgione E; Iorio R; Ventola GM; Marchese G; Salluzzo MG; Ravo M; Ferri R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163455
[TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNAs in Parkinson's Disease.
Xin C; Liu J
Neurochem Res; 2021 May; 46(5):1031-1042. PubMed ID: 33544326
[TBL] [Abstract][Full Text] [Related]
10. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.
Manna I; Quattrone A; De Benedittis S; Iaccino E; Quattrone A
J Parkinsons Dis; 2021; 11(4):1475-1489. PubMed ID: 34334422
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease.
Huang T; Zhao JY; Pan RR; Jiang T; Fu XX; Huang Q; Wang XX; Gong PY; Tian YY; Zhang YD
Mol Neurobiol; 2023 Jan; 60(1):317-328. PubMed ID: 36264433
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease.
Li J; Sun Y; Chen J
Genes Genet Syst; 2019 Apr; 94(2):61-69. PubMed ID: 30713215
[TBL] [Abstract][Full Text] [Related]
13. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
Sivagurunathan N; Ambatt ATS; Calivarathan L
Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
[TBL] [Abstract][Full Text] [Related]
14. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease.
Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B
Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570
[TBL] [Abstract][Full Text] [Related]
15. Significant Role of Long Non-coding RNAs in Parkinson's Disease.
Na C; Wen-Wen C; Li W; Ao-Jia Z; Ting W
Curr Pharm Des; 2022; 28(37):3085-3094. PubMed ID: 36154598
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.
Bao J; Chang W; Zhao Y
J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466
[TBL] [Abstract][Full Text] [Related]
17. Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
Li F; Huang C; Li Q; Wu X
Med Sci Monit; 2018 Jan; 24():37-49. PubMed ID: 29295970
[TBL] [Abstract][Full Text] [Related]
18. Genome-Scale Expression Pattern of Long Non-Coding RNAs in Chinese Uyghur Patients with Parkinson's Disease.
Wang D; Gao H; Li Y; Jiang S; Yong Y; Yang X
Med Sci Monit; 2020 Oct; 26():e925888. PubMed ID: 33031356
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum lncRNA H19, GAS5, HAR1B and linc01783 levels in Parkinson's disease.
Ozdilek B; Kaya Alper I; Demircan B; Tombul T; Ankarali H
Ideggyogy Sz; 2023 May; 76(5-6):189-196. PubMed ID: 37294024
[TBL] [Abstract][Full Text] [Related]
20. The roles of non-coding RNAs in Parkinson's disease.
Majidinia M; Mihanfar A; Rahbarghazi R; Nourazarian A; Bagca B; Avci ÇB
Mol Biol Rep; 2016 Nov; 43(11):1193-1204. PubMed ID: 27492082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
